Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528677 | Current Opinion in Pharmacology | 2018 | 9 Pages |
Abstract
Statins and ACE inhibitors have been shown to enhance endogenous nitric oxide and improve intermittent claudication symptoms. Studies using l-arginine have produced differing results, for reasons for yet fully understood. A greater understanding of the nitric oxide pathway, and its enzymatic control, has generated more potential therapeutic targets to alter NO levels.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Debbie Falconer, Nikolaos Papageorgiou, Karim Salem, Wei Yao Lim, Athanasios Katsargyris, Efthimios Avgerinos, Dimitris Tousoulis,